FiercePharmaAsia—Possible Sun probe; Huahai warning letter; Eisai-UCL neuro pact

14th December 2018 Uncategorised 0

India’s securities regulators say they’re examining whistleblower allegations against Sun; the Chinese API maker at the heart of a global recall of valsartan gets an FDA warning letter; Eisai and University College London push the first candidate in their neuro pact into the clinic; and more.

More: FiercePharmaAsia—Possible Sun probe; Huahai warning letter; Eisai-UCL neuro pact
Source: fierce